Log has written
SATURDAY, NOVEMBER 28, 2009 10:06 AM IST
Malvinder Singh
  
PTI   06:49 PM | October 09,2009
The company will issue over 9.06 crore shares under the rights offering to its existing shareholders
PTI   02:48 PM | August 16,2009
Malvinder Singh’s remuneration was in excess of the prescribed regulatory limits and Ranbaxy is waiting for the shareholders’ nod to seek the waiver of relevant norms from the central government
Shereen Bhan / CNBC-TV18   10:34 PM | July 10,2009
Malvinder Singh, says that he is focusing on expanding his financial services firm Religare Enterprises Ltd and hospital chain Fortis Healthcare Ltd
Radhieka Pandeya   01:15 AM | May 25,2009
Atul Sobti will be the new chief executive and managing director; Tsutomu Une promoted as the new chairman
PTI   06:56 PM | May 24,2009
The change of guard comes nearly a year after Ranbaxy was acquired by Japanese drug major Daiichi-Sankyo
Radhieka Pandeya   12:47 AM | January 23,2009
The firm reported a net loss of Rs680 crore, compared with a net profit of Rs188 crore in year-ago quarter
PTI  12:52 PM | January 21,2009
The total income, however, rose 19.27% to Rs45.93 crore during the quarter under review
Radhieka Pandeya   09:19 PM | January 08,2009
Analysts say the firm filed the generic drug application from a facility that is under the US FDA scanner
C.H. Unnikrishnan  11:24 PM | November 09,2008
LifeKen, which has been making annual losses of at least Rs12 crore since 2005, has been valued at less than Rs7 crore
  02:13 PM | October 14,2008
Ranbaxy has been marred by allegations that it sold misbranded or adulterated drugs in the United States
Saikat Chatterjee and Cherian Thomas / Bloomberg  12:31 AM | October 04,2008
Daiichi Sankyo, which aims to complete the transaction by March, still needs approval of the Reserve Bank of India
  01:21 PM | August 05,2008
The open offer, which closes on 4 September, would be at Rs737 per share, the same price it had paid the founding family
  01:30 PM | July 18,2008
Recently, the Department of Justice filed a motion in the US court against Ranbaxy alleging systematic fraudulent conduct
Ashwin Ramarathinam and Nesil Staney  07:48 PM | July 12,2008
The top paid executives got an average 64% pay hike last year, far above the average rise in profits, stock prices
  03:33 PM | June 21,2008
Malvinder says company would continue to grow, talks of separating ownership and management
1 2